Clinical trial
Repeated Cross Sectional Surveillance Study To Determine the Influenza Vaccination Rates in German Participants During Current Respiratory Season
NCT06800885 is registered in ClinicalTrials.gov with Sanofi Pasteur, a Sanofi Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Repeated Cross Sectional Surveillance Study To Determine the Influenza Vaccination Rates in German Participants During Current Respiratory Season
- Lead sponsor
- Sanofi Pasteur, a Sanofi Company
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 22, 2024
- Completion date
- February 22, 2026
- Enrollment
- 5,000 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
influenza immunization